Myasthenia gravis with thymic hyperplasia is associated with polymorphisms in the tumor necrosis factor region.
Hjelmström
P
P
Department of Medicine, Karolinska Institute, Karolinska Hospital, Stockholm, Sweden.
Peacock
C S
CS
Giscombe
R
R
Pirskanen
R
R
Lefvert
A K
AK
Blackwell
J M
JM
Sanjeevi
C B
CB
D000071450:ATP Binding Cassette Transporter, Subfamily B, Member 3; D018528:ATP-Binding Cassette Transporters / Q000235:genetics; D000328:Adult; D000483:Alleles; D005260:Female; D006683:HLA-DQ Antigens / Q000235:genetics; D059866:HLA-DQ beta-Chains; D015803:HLA-DR3 Antigen / Q000235:genetics; D006239:Haplotypes; D006801:Humans; D006965:Hyperplasia; D008233:Lymphotoxin-alpha / Q000235:genetics; D008285:Major Histocompatibility Complex; D008297:Male; D018895:Microsatellite Repeats; D009157:Myasthenia Gravis / Q000235:genetics* / Q000276:immunology* / Q000473:pathology; D012150:Polymorphism, Restriction Fragment Length; D012016:Reference Values; D013950:Thymus Gland / Q000473:pathology*; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics*
D000071450:ATP Binding Cassette Transporter, Subfamily B, Member 3; D018528:ATP-Binding Cassette Transporters; D006683:HLA-DQ Antigens; D059866:HLA-DQ beta-Chains; C069051:HLA-DQB1 antigen; D015803:HLA-DR3 Antigen; D008233:Lymphotoxin-alpha; D014409:Tumor Necrosis Factor-alpha; C071692:TAP2 protein, human